terlipressin has been researched along with Cirrhoses, Experimental Liver in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alegre, F; Banales, JM; Barbero, R; Carreño, N; Chang, HC; García, M; Herrero, I; Morán, A; Pérez-Vizcaíno, F; Prieto, J; Quiroga, J; Reboredo, M; Rodríguez-Ortigosa, CM; Sangro, B | 1 |
| Cailmail, S; Hadengue, A; Lebrec, D; Moreau, R; Oberti, F; Sogni, P | 1 |
2 other study(ies) available for terlipressin and Cirrhoses, Experimental Liver
| Article | Year |
|---|---|
Zolmitriptan: a novel portal hypotensive agent which synergizes with propranolol in lowering portal pressure.
Topics: Adrenergic beta-Antagonists; Animals; Antihypertensive Agents; Body Weight; Carbon Tetrachloride; Catecholamines; Common Bile Duct; Cyclic AMP; Drug Synergism; Drug Therapy, Combination; Hypertension, Portal; Infusions, Intravenous; Ligation; Liver Cirrhosis, Experimental; Lypressin; Mesenteric Artery, Superior; Oxazolidinones; Perfusion; Portal Pressure; Propranolol; Rats; Regional Blood Flow; Renal Artery; Splanchnic Circulation; Sympathectomy; Terlipressin; Tryptamines; Vasodilation | 2013 |
Effects of terlipressin on hemodynamics and oxygen content in conscious portal vein stenosed and cirrhotic rats receiving propranolol.
Topics: Animals; Blood Pressure; Carbon Dioxide; Heart Rate; Hemodynamics; Hydrogen-Ion Concentration; Hypertension, Portal; Liver Circulation; Liver Cirrhosis, Experimental; Lypressin; Male; Oxygen; Oxygen Consumption; Partial Pressure; Portal System; Portal Vein; Propranolol; Rats; Rats, Sprague-Dawley; Splanchnic Circulation; Terlipressin; Vascular Resistance | 1993 |